Nicox SA
PAR:ALCOX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nicox SA
PAR:ALCOX
|
FR |
|
A
|
Alibaba Group Holding Ltd
LSE:0HCI
|
CN |
|
Rizzoli Corriere della Sera Mediagroup SpA
MIL:RCS
|
IT |
|
NUGL Inc
OTC:NUGL
|
US |
|
A
|
American International Group Inc
XETRA:AINN
|
US |
|
K
|
KLA Corp
XBER:KLA
|
US |
|
W
|
Westlake Corp
LSE:0LVK
|
US |
|
Husqvarna AB
STO:HUSQ B
|
SE |
|
Industrivarden AB
LSE:0H13
|
SE |
|
Tower One Wireless Corp
F:1P3N
|
CA |
|
C
|
Costco Wholesale Corp
XHAM:CTO
|
US |
Nicox SA
Nicox SA is an ophthalmology company. The company is headquartered in Valbonne, Paca. The company is engaged in the field of the research, development and future commercialization of investigational drugs for ophthalmological diseases. The Company’s aim is to build a portfolio of therapeutic products addressing the needs of eye care practitioners and patients. Nicox SA offers its customers the Xailin range of ocular lubricants and AdenoPlus, a diagnostic test that aids in the differential diagnosis of acute conjunctivitis. The firm has also products in the pipeline, such as VESNEO (a drug-candidate for treating glaucoma) and AC-170 (for allergic conjunctivis). The company has a direct commercial presence in Germany, France, the United Kingdom, Italy and Spain, as well as partnerships with local distributors in a number of key international markets.
Nicox SA is an ophthalmology company. The company is headquartered in Valbonne, Paca. The company is engaged in the field of the research, development and future commercialization of investigational drugs for ophthalmological diseases. The Company’s aim is to build a portfolio of therapeutic products addressing the needs of eye care practitioners and patients. Nicox SA offers its customers the Xailin range of ocular lubricants and AdenoPlus, a diagnostic test that aids in the differential diagnosis of acute conjunctivitis. The firm has also products in the pipeline, such as VESNEO (a drug-candidate for treating glaucoma) and AC-170 (for allergic conjunctivis). The company has a direct commercial presence in Germany, France, the United Kingdom, Italy and Spain, as well as partnerships with local distributors in a number of key international markets.
